DCAT: Drug, Chemical & Associated Technologies Association Week  

Our combination product experts will be in attendance at DCAT Week 2024; schedule time to discuss your therapy and our innovative solutions.  

Capital Expansions & Acquisitions in Drug-Device Combination Products

March 18, 2024 
10:15-10:22 a.m. 
InterContinental Barclay, Grand Ballroom (2^nd Floor) 

Join Kindeva’s CEO, Milton Boyer, to discover how we are growing our drug-device combination product capabilities through strategic capital expansions and acquisitions. This presentation at the DCAT Member Announcement Forum will explore our $150M+ investment in our Bridgeton, MO, aseptic injectable fill-finish facility; our acquisition of Summit Biosciences, Inc. and the resulting expansion in our intranasal drug delivery capabilities; and our low-GWP propellant partnerships and sustainability initiatives. 

DCAT Presentation Sponsored by Kindeva Drug Delivery

Explore the Future of Pharma 

March 18, 2024 
2:30-4:30 p.m.  
InterContinental Barclay, Grand Ballroom (2^nd Floor)  

Delve into the bio/pharmaceutical industry’s performance in 2023 and outlook for 2024 in this presentation featuring Graham Lewis, IQVIA’s Vice President of Global Pharma Strategy, and Daniel Cohen, Morgan Stanley’s Managing Director, Investment Banking Division, sponsored by Kindeva Drug Delivery. Pharma Industry Outlook is consistently the most popular DCAT Week program, and this year’s iteration is sure to provide comprehensive insights in an easy-to-digest format.  

Schedule a Meeting